Guardant Health Q2 EPS $(1.00) Beats $(1.21) Estimate, Sales $109.14M Beat $104.89M Estimate
Guardant Health (NASDAQ:GH) reported quarterly losses of $(1.00) per share which beat the analyst consensus estimate of $(1.21) by 17.36 percent. This is a 63.93 percent decrease over losses of $(0.61) per share from the